Year: 2025

Conference Call Scheduled for November 4th at 8:30 AM ET NEWBURYPORT, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) — UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced that the Company plans to report results for the third quarter on Monday, November 3rd, after the close of the stock market. The Company will hold a conference call to discuss the results on the following day, November 4th, at 8:30 AM Eastern time. Conference Call Information:Date: Tuesday, November 4, 2025Time: 8:30 AM Eastern Time Participants may join the call using the following dial-in numbers:USA/Canada: Toll-Free: 1-412-206-6478 International: 1-833-890-4010A live webcast of the conference call and accompanying materials will be available...

Peer-Reviewed Study Conducted in Collaboration with Mayo Clinic Demonstrates 100% Sensitivity and Strong Predictive Power for Esophageal Cancer Progression Early Access Programs and Physician Onboarding Initiatives Expected to Begin in Early 2026 UNIONDALE, NY, Oct. 29, 2025 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH) today announced that its study, “Assessing Risk of Progression in Barrett’s Esophagus Using a Mass-Spectrometry-Based Proteomic Panel,” has been published online in Clinical and Translational Gastroenterology, the official journal of the American College of Gastroenterology (ACG). The publication presents full clinical validation data supporting BE-Smart, an 8-protein, mass-spectrometry-based proteomic assay developed for risk stratification of patients with Barrett’s Esophagus (BE). Conducted in collaboration...

PETACH TIKVA, Israel, Oct. 29, 2025 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its third quarter 2025 financial results and operational highlights before the open of the U.S. financial markets on Wednesday, November 12, 2025. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations. To ensure you are connected prior to the beginning of the call, PolyPid suggests registering a minimum of 5 minutes before the start of the call. For those not planning to ask a question of management, the Company recommends listening via the webcast. Conference Call Dial-In & Webcast Information:Date: Wednesday,...

SHENZHEN, China, Oct. 29, 2025 (GLOBE NEWSWIRE) — Jayud Global Logistics Limited (NASDAQ: JYD) (“Jayud” or the “Company”), a leading end-to-end supply chain solution provider based in Shenzhen, specializing in cross-border logistics, today announced that it has entered into multiple international freight logistics agreements with major multinational corporations. These include Chongqing Chuandong Chemical (Group) Limited, established in 1958, a leading chemical manufacture in Chongqing and ranked Top 10 Enterprises in the Phosphorus Chemical Industry in China with annul revenue over RMB 5 billion; and Yaxinke International Forging (Shanxi) Limited (also know as Asimco Technologies Lmited), founded in the 1997, a leading casting and forging company supplying casting engine parts for Caterpillar, Komatsu,...

MIDLAND, Texas, Oct. 29, 2025 (GLOBE NEWSWIRE) — Natural Gas Services Group, Inc. (NYSE:NGS), a leading provider of natural gas compression equipment, technology and services to the energy industry, announced today that it will host a conference call to review its third quarter 2025 financial results on November 11, 2025, at 8:30 a.m. (EST), 7:30 a.m. (CST). The Company’s Q3 2025 financial and operating results for the three months ended September 30, 2025 will be disseminated via press release and made available on the Company’s website (www.ngsgi.com) after market close on November 10, 2025. To join the conference call, kindly access the Investor Relations section of our website at www.ngsgi.com or dial in at (800) 550-9745 and enter conference ID: 167298 at least five minutes prior to the scheduled start time. Please note that...

This article has been disseminated on behalf of LaFleur Minerals, and it may include a paid advertisement. NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) — via InvestorWire — LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF)  today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “Pivoting from Exploration to Production: Mining’s Moment,” please visit: https://nnw.fm/UN3iH Over the past year, gold, silver and other precious metals have staged a consistent up-move that is reshaping the investment case for the mining sector. Driven by...

SUMMIT, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) — Aterian, Inc. (Nasdaq: ATER), a consumer products company, today announced that its hOmeLabs brand line of dehumidifiers is now available on homedepot.com.   The Company’s portfolio of hOmeLabs dehumidifiers are designed to make everyday living healthier and more efficient. hOmeLabs dehumidifiers blend high performance with sleek, modern design and features that include user-friendly controls, Energy Star ratings, easy portability, and Wi-Fi enabled operations. Customers can say goodbye to excess moisture and hello to comfort with hOmeLabs dehumidifiers to create a healthier, fresher living space. “We are thrilled to expand our relationship with Home Depot with the introduction of our hOmeLabs line of dehumidifiers,” said Arturo Rodriguez, Chief Executive Officer of Aterian. “Home...

HOUSTON, TX, Oct. 29, 2025 (GLOBE NEWSWIRE) — Houston American Energy Corp. (NYSE American: HUSA) (“HUSA” or the “Company”) and its wholly owned subsidiary, Abundia Global Impact Group, LLC (“AGIG”), are pleased to announce the groundbreaking for Phase One of the Company’s Cedar Port development plan in Baytown, Texas (“Phase One”). This milestone marks the start of construction on the Abundia Innovation Center (the “Abundia Innovation Center”) and the Research and Development Facility (the “R&D Facility”). Together, these two complementary buildings will anchor HUSA’s vision to scale and commercialize circular-economy and renewable-fuel solutions. Phase One is being delivered by Corvus Construction Company, Inc. under the previously announced design-build agreement, with Powers Brown Architecture providing architectural services,...

PEKIN, Ill., Oct. 29, 2025 (GLOBE NEWSWIRE) — Alto Ingredients, Inc. (NASDAQ: ALTO) a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced it will release its third quarter 2025 financial results after the close of market on Wednesday, November 5, 2025. Management will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time and will deliver prepared remarks via webcast followed by a question-and-answer session. How to participate:To listen to the webcast, visit the Alto Ingredients website. To receive a number and unique PIN by email, register here. To dial directly twenty minutes prior to the scheduled call time, dial (833) 630-0017 domestically and (412) 317-1806 internationally. Please ask to join Alto Ingredients.The webcast will be archived for...

Kennewick, WA, Oct. 29, 2025 (GLOBE NEWSWIRE) — Vivos Inc. (OTCQB: RDGL) today announced enhanced cooperation with Exubrion Therapeutics to advance the use of targeted radioactive isotope technology for multiple indications in companion animals. The two companies have agreed to broaden their joint efforts in several key areas — including shared clinic relationships, licensing coordination, and manufacturing optimization. These initiatives build upon prior collaborations involving device classification, development of clinician training modules, and educational seminars. “Our companies complement one another exceptionally well,” said Dr. Michael K. Korenko, Chief Executive Officer of Vivos Inc. “Exubrion’s focus on treating osteoarthritis pain in companion animals and Vivos’s work in cancer therapy represent distinct markets, enabling...